Al A. Sikder
Brisbane, QLD 4072, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma.
Journal: Nature communications
Published: November 26, 2023
Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection.
Journal: Immunity
Published: July 19, 2022
Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma.
Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma.
Journal: American journal of respiratory and critical care medicine
Published: December 03, 2021
IFN-λ Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 09, 2021
HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling.
Journal: PLoS pathogens
Published: March 10, 2020
PAG1 limits allergen-induced type 2 inflammation in the murine lung.
Journal: Allergy
Published: March 31, 2019
Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion.
Journal: The Journal of experimental medicine
Published: February 15, 2017
The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?
Journal: Frontiers in immunology
Published: December 13, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026